Cytosorbents Corp Files 8-K on Financials
Ticker: CTSO · Form: 8-K · Filed: Aug 14, 2024 · CIK: 1175151
| Field | Detail |
|---|---|
| Company | Cytosorbents CORP (CTSO) |
| Form Type | 8-K |
| Filed Date | Aug 14, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: financial-condition, results-of-operations, 8-k
TL;DR
Cytosorbents filed an 8-K detailing their latest financial results.
AI Summary
Cytosorbents Corporation filed an 8-K on August 14, 2024, reporting on its results of operations and financial condition as of August 13, 2024. The filing details financial statements and exhibits related to the company's performance.
Why It Matters
This 8-K filing provides crucial updates on Cytosorbents Corporation's financial health and operational results, which can influence investor decisions.
Risk Assessment
Risk Level: low — This filing is a routine disclosure of financial information and does not indicate any immediate or significant risks.
Key Players & Entities
- Cytosorbents Corporation (company) — Registrant
- August 13, 2024 (date) — Date of Earliest Event Reported
- August 14, 2024 (date) — Date of Report
- 305 College Road East Princeton, New Jersey 08540 (address) — Principal executive offices
FAQ
What is the primary purpose of this 8-K filing?
The primary purpose of this 8-K filing is to report on Cytosorbents Corporation's results of operations and financial condition, along with providing financial statements and exhibits.
What is the date of the earliest event reported in this filing?
The date of the earliest event reported in this filing is August 13, 2024.
What is the filing date of this 8-K report?
This 8-K report was filed on August 14, 2024.
Where are Cytosorbents Corporation's principal executive offices located?
Cytosorbents Corporation's principal executive offices are located at 305 College Road East, Princeton, New Jersey 08540.
What is the Commission File Number for Cytosorbents Corporation?
The Commission File Number for Cytosorbents Corporation is 001-36792.
Filing Stats: 507 words · 2 min read · ~2 pages · Grade level 10.5 · Accepted 2024-08-13 17:40:54
Key Financial Figures
- $0.001 — e on which registered Common Stock, $0.001 par value CTSO The Nasdaq Stock Marke
Filing Documents
- tm2421554d1_8k.htm (8-K) — 27KB
- tm2421554d1_ex99-1.htm (EX-99.1) — 142KB
- tm2421554d1_ex99-1img001.jpg (GRAPHIC) — 13KB
- 0001104659-24-089068.txt ( ) — 376KB
- ctso-20240813.xsd (EX-101.SCH) — 3KB
- ctso-20240813_lab.xml (EX-101.LAB) — 33KB
- ctso-20240813_pre.xml (EX-101.PRE) — 22KB
- tm2421554d1_8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: August 13, 2024 CYTOSORBENTS CORPORATION By: /s/ Dr. Phillip P. Chan Name: Dr. Phillip P. Chan Title: Chief Executive Officer